Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/109602

Effect of Maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals
Kawana-Tachikawa, Ai; Llibre, Josep M.; Bravo, Isabel; Escrig, Roser; Mothe, Beatriz; Puig, Jordi; Puertas, Maria C.; Martínez Picado, Francisco Javier; Blanco, Julià; Manzardo, Christian; Miró Meda, José M.; Iwamoto, Aikichi; Pozniak, Anton L.; Gatell, José M.; Clotet i Sala, Bonaventura; Brander, Christian
Universitat de Barcelona
BACKGROUND: The effect of maraviroc on the maintenance and the function of HIV-1-specific T cell responses remains unknown. METHODS: Subjects recently infected with HIV-1 were randomized to receive anti-retroviral treatment with or without maraviroc intensification for 48 weeks, and were monitored up to week 60. PBMC and in vitro-expanded T cells were tested for responses to the entire HIV proteome by ELISpot analyses. Intracellular cytokine staining assays were conducted to monitor the (poly)-functionality of HIV-1-specific T cells. Analyses were performed at baseline and week 24 after treatment start, and at week 60 (3 months after maraviroc discontinuation). RESULTS: Maraviroc intensification was associated with a slower decay of virus-specific T cell responses over time compared to the non-intensified regimen in both direct ex-vivo as well as in in-vitro expanded cells. The effector function profiles of virus-specific CD8⁺ T cells were indistinguishable between the two arms and did not change over time between the groups. CONCLUSIONS: Maraviroc did not negatively impact any of the measured parameters, but was rather associated with a prolonged maintenance of HIV-1-specific T cell responses. Maraviroc, in addition to its original effect as viral entry inhibitor, may provide an additional benefit on the maintenance of virus-specific T cells which may be especially important for future viral eradication strategies.
-Cèl·lules T
-VIH (Virus)
-Antiretrovirals
-Resposta immunitària
-Genètica molecular
-T cells
-HIV (Viruses)
-Antiretroviral agents
-Immune response
-Molecular genetics
cc-by (c) Kawana-Tachikawa, Ai et al., 2014
http://creativecommons.org/licenses/by/3.0/es
Artículo
Artículo - Versión publicada
Public Library of Science (PLoS)
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Massanella, Marta; Ouchi, Dan; Marfil, Silvia; Llibre, Josep M.; Puertas, Maria C.; Buzón, María J.; Richman, Douglas D.; Orna, Elisa; Stevenson, Mario; Gatell, José M.; Domingo, Pere (Domingo Pedrol); Negredo, Eugènia; Martínez Picado, Francisco Javier; Clotet i Sala, Bonaventura; Blanco, Julià
Kawana-Tachikawa, A.; Llibre, Josep M.; Bravo, Isabel; Escrig, R.; Mothe, B.; Puig, Jordi; Puertas, M.C.; Martinez Picado, Francisco Javier; Blanco, Julià; Manzardo, C.; Miró, J.M.; Iwamoto, A.; Pozniak, A.L.; Gatell, J.M.; Clotet, Bonaventura; Brander, Christian
Massanella, Marta; Ouchi, Dan; Marfil, Silvia; Llibre, Josep María; Puertas, Maria C.; Buzón, María J.; Richman, Douglas D.; Orna, Elisa; Stevenson, Mario; Gatell, José M.; Domingo, Pere (Domingo Pedrol); Negredo, Eugenia; Martínez Picado, Francisco Javier; Clotet i Sala, Bonaventura; Blanco, Julià
Llibre, Josep M.; Bravo, Isabel; Ornelas, Arelly; Santos, José R.; Puig, Jordi; Martín Iguacel, Raquel; Paredes, Roger; Clotet, Bonaventura
Ambrosioni, Juan; Sued, Omar; Nicolas, David; Parera, Marta; López-Diéguez, María; Romero, Anabel; Agüero Santangelo, Fernando; Marcos Maeso, Ma. Angeles; Manzardo, Christian; Zamora, Laura; Gómez-Carrillo, Manuel; Gatell, José M.; Pumarola Suñé, Tomás; Miró Meda, José M.